The Impact of Nursing Delirium Preventive Interventions in the Intensive Care Unit (UNDERPIN-ICU)

October 8, 2020 updated by: Radboud University Medical Center

The Impact of nUrsiNg DEliRium Preventive INterventions in the Intensive Care Unit (UNDERPIN-ICU): A Multi-centre, Stepped Wedge Randomized Controlled Trial

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, and determines the effect of the program on the number of delirium-coma-free days in 28 days and several secondary outcomes in a multicenter randomized controlled trial.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Delirium is a common disorder in Intensive Care Unit (ICU) patients and is associated with serious short- and long-term consequences, including re-intubations, ICU readmissions, prolonged ICU and hospital stay, persistent cognitive problems, and higher mortality rates. Considering the high incidence of delirium and its consequences, prevention of delirium is imperative. This study focuses on a program of standardized nursing and physical therapy interventions to prevent delirium in the ICU, called UNDERPIN-ICU (nUrsiNg DEliRium Preventive INterventions in the ICU).

Objective: To determine the effect of the UNDERPIN-ICU program on the number of delirium-coma-free days in 28 days and several secondary outcomes, such as delirium incidence, the number of days of survival in 28 and 90 days and delirium-related outcomes.

Design and Setting: A multicenter stepped wedge cluster randomized controlled trial.

Methods: Eight to ten Dutch ICUs will implement the UNDERPIN-ICU program in a randomized order. Every two months the UNDERPIN-ICU program will be implemented in an additional ICU following a two months period of staff training. UNDERPIN-ICU consists of standardized protocols focusing on several modifiable risk factors for delirium, including cognitive impairment, sleep deprivation, immobility and visual and hearing impairment.

Participants: ICU patients aged ≥ 18 years (surgical, medical, or trauma) and at high risk for delirium, E-PRE-DELIRIC ≥35%, will be included, unless delirium was detected prior ICU admission, expected length of ICU stay is less then one day or when delirium assessment is not possible.

Study Type

Interventional

Enrollment (Actual)

1750

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Den Haag, Netherlands
        • Haaglanden Medical Center location Westeinde
      • Ede, Netherlands
        • Hospital Gelderse Vallei
      • Enschede, Netherlands
        • Medical spectrum Twente
      • Harderwijk, Netherlands
        • Hospital St. Jansdal
      • Leeuwarden, Netherlands
        • Medical Center Leeuwarden
      • Tilburg, Netherlands
        • Hospital ETZ location Elisabeth
      • Tilburg, Netherlands
        • Hospital ETZ location Tweesteden
      • Uden, Netherlands
        • Bernhoven Hospital
      • Veldhoven, Netherlands
        • Maxima Medical Center
      • Zwolle, Netherlands
        • Isala Clinics
    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6500HB
        • Radboud University Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged ≥ 18 years
  • surgical, medical or trauma patients
  • admitted to one of the participating ICUs
  • at high risk for delirium (>35% determined with the E-PRE-DELIRIC prediction tool)

Exclusion Criteria:

  • delirious before ICU admission
  • an ICU stay < one day
  • reliable assessment for delirium is not possible due to: sustained coma; serious auditory or visual disorders; inability to understand Dutch; severely mentally disabled; serious receptive aphasia.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control - standard care
Prior to implementation of the intervention package the current standard of care will be maintained.
Active Comparator: Intervention group
After implementation the intervention package will be implemented as standard care.
UNDERPIN-ICU consists of standardized protocols focusing on several modifiable risk factors for delirium, including cognitive impairment, sleep deprivation, immobility and visual and hearing impairment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of delirium-coma-free days
Time Frame: 28 days
The number of days a patient is not delirious and not in coma in 28 days starting from the day of inclusion in the study after ICU admission.
28 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium incidence
Time Frame: 28 days
One or more episodes of positive delirium screening after ICU admission.
28 days
The number of days of survival
Time Frame: 28 days
The number of days survived since ICU admission.
28 days
The number of days of survival
Time Frame: 90 days
The number of days survived since ICU admission.
90 days
Duration of mechanical ventilation
Time Frame: 28 days
The number of days a patient was mechanically ventilated.
28 days
Incidence of re-intubation
Time Frame: 28 days
Patients who need to be intubated within 28 days after ICU admission, following a previous extubation, irrespectively the reason for re-intubation, will be counted as incident case for re-intubation.
28 days
Incidence of ICU re-admission
Time Frame: 28 days
Patients who need to be readmitted to the ICU within 28 days, irrespectively the reason for readmission, will be counted as incident cases for ICU readmission.
28 days
Incidence of unplanned removal of tubes/catheters
Time Frame: 28 days
Incidents in which patients remove their tube or catheter themselves will be counted as incident cases for unplanned removal. The period in which this is measured is during patients' ICU stay or during the period when the patient is delirious (in case a patient is discharged to the ward) with a maximum of 28 days.
28 days
Incidence of physical restraints
Time Frame: 28 days
Patients who need physical restraints (fixation of their limbs to prevent them from removing tubes or lines) within 28 days, will be counted as incident cases for physical restraints.
28 days
ICU length of stay
Time Frame: 365 days
This is defined as the number of days a patient is admitted to the ICU. Hospital length of stay is defined as number of days a patient is admitted to the hospital.
365 days
Hospital length of stay
Time Frame: 365 days
This is defined as the number of days a patient is admitted to the ICU. Hospital length of stay is defined as number of days a patient is admitted to the hospital.
365 days
Health related quality of Life (HRQoL)
Time Frame: 90 days after ICU admission
90 days after ICU admission
Health related quality of Life (HRQoL)
Time Frame: 365 days after ICU admission
365 days after ICU admission
Post-hoc analysis
Time Frame: During admission
During admission
Cost-effectiveness
Time Frame: During ICU admission
During ICU admission

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mark van den Boogaard, PhD, Radboud University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 31, 2016

Primary Completion (Actual)

May 31, 2019

Study Completion (Actual)

May 31, 2020

Study Registration Dates

First Submitted

November 25, 2016

First Submitted That Met QC Criteria

December 21, 2016

First Posted (Estimate)

December 26, 2016

Study Record Updates

Last Update Posted (Actual)

October 9, 2020

Last Update Submitted That Met QC Criteria

October 8, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delirium

Clinical Trials on UNDERPIN-ICU program

Subscribe